Literature DB >> 6224740

Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages.

M R Daha, L A Van Es.   

Abstract

Previous studies have shown that the degradation of soluble immune complexes or aggregates (AIgG) by normal peritoneal macrophages can be enhanced by complement. The enhancement of degradation was shown to be at least in part dependent on the number of C3b molecules bound per complex. The present investigations indicate that the enhanced degradation is not found with thioglycollate-stimulated macrophages, and that at high concentrations of complement, inhibition may even occur. The Fc receptor-mediated degradation of soluble immune complexes and AIgG by stimulated macrophages was at least twice as high as that by normal macrophages. This increase was compatible with the increased number of Fc receptors on the stimulated macrophages. The inhibitory effect of high concentrations of serum, as a complement source, on the degradation of AIgG was dependent on the number of C3b molecules bound per AIgG. Although there was also a two-fold increase in the number of C3b receptor sites on the stimulated macrophages, more than 11 C3b molecules per AIgG40 caused significant inhibition of degradation. This phenomenon may be dependent on shielding of Fc-Fc receptor interaction by varying numbers of C3b molecules per complex.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224740      PMCID: PMC1454238     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

Review 1.  Cytophilic antibodies.

Authors:  R G Leslie; M D Alexander
Journal:  Curr Top Microbiol Immunol       Date:  1979       Impact factor: 4.291

2.  Cloned macrophages can be induced to kill tumor cells.

Authors:  C C Stewart; C Adles; J B Hibbs
Journal:  J Reticuloendothel Soc       Date:  1978-08

3.  Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement.

Authors:  A Kijlstra; L A van Es; M R Daha
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

4.  The kinetics for binding and catabolism of aggregated IgG by rat peritoneal macrophages.

Authors:  D W Knutson; A Kijlstra; L A van Es
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

5.  The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages.

Authors:  A Kijlstra; L A van Es; M R Daha
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement.

Authors:  A Kijlstra; L A Van Es; M R Daha
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

7.  Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.

Authors:  J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

8.  Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection.

Authors:  R H Kauffmann; L A Van Es; M R Daha
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

9.  The effect of complement on the ingestion of soluble antigen-antibody complexes and IgM aggregates by mouse peritoneal macrophages.

Authors:  J L van Snick; P L Masson
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Association and dissociation of aggregated IgG from rat peritoneal macrophages.

Authors:  D W Knutson; A Kijlstra; L A Van Es
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  2 in total

1.  C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E De Vries; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

2.  Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).

Authors:  N Madi; G Steiger; J Estreicher; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.